Cigarette smoking, like many addictive behaviors, has a genetic component, and the dopamine D2-like receptor genes (DRD2, DRD3 and DRD4) are candidates for contributing to these behaviors. Phenotypic information concerning smoking-related behaviors from a nationally representative sample of research volunteers was analyzed for association with polymorphisms in these genes. Genotype status at the DRD2 intron 2 simple tandem repeat was related to cigarettes per day (P = 0.035) and heaviness of smoking index (P = 0.049). The presence of the glycine allele at the S9G polymorphism of the DRD3 gene was associated with frequency/quantity measures of smoking [log-transformed time to first cigarette (P = 0.031) and heaviness of smoking index (P = 0.035)]. There was a trend for DRD4 long alleles of the variable number of tandem repeats polymorphism to be associated with reduced severity of three withdrawal symptoms [desire/craving (P = 0.054); anger/irritability (P = 0.10); and trouble sleeping (P = 0.068)]. Interactions between genotypes at all three genes were associated with nervousness (P = 0.020) and trouble sleeping (P = 0.015). An interaction between DRD2 and DRD3 was found for trouble concentrating (P = 0.020). These relationships present possible dopamine-related responses to nicotine that warrant further study.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1369-1600.2007.00054.xDOI Listing

Publication Analysis

Top Keywords

drd2 drd3
12
receptor genes
8
genes drd2
8
drd3 drd4
8
smoking-related behaviors
8
heaviness smoking
8
trouble sleeping
8
dopamine receptor
4
genes
4
drd2
4

Similar Publications

Pediatric autoimmune neuropsychiatric disorders associated with or without streptococcal and other bacterial infections (PANDAS/CANS) are emerging as a featured pediatric disorder. Although there is some controversy regarding treatment approaches, especially related to the behavioral sequelae, we have hypothesized in other published work that it is characterized by the rapid onset of Reward Deficiency Syndrome (RDS) in children. We propose utilizing a multi-systems biological approach involving the coupling of genetic addiction risk testing and pro-dopamine regulation (KB220/POLYGEN) to help induce "dopamine homeostasis" in patients with PANDAS, especially those with known DNA-induced hypodopaminergia.

View Article and Find Full Text PDF

Genetic polymorphisms and bruxism: A scoping review.

Sleep Med

December 2024

Brazilian Centre for Evidence-Based Research (COBE), Department of Dentistry, Federal University of Santa Catarina (UFSC), Florianópolis, Brazil.

Article Synopsis
  • - The study explores bruxism's complex origins, noting that both genetic and non-genetic factors contribute to its development, but the role of genetic markers is still not well understood.
  • - Researchers analyzed 21 reports, including 16 original studies, focusing on genetic associations with sleep bruxism (SB) and awake bruxism (AB), identifying 15 significant genetic polymorphisms across 11 genes.
  • - Findings suggest specific genes associated with SB (like serotonergic and dopaminergic pathways) and AB (like ACTN3 and ANKK1), indicating potential genetic influences but highlighting the need for further research.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers used an advanced technique called RNAScope to measure the levels of three dopamine receptors (Drd1, Drd2, Drd3) in specific brain regions related to song control in male and female canaries, who were treated with testosterone to promote singing activity.
  • The study found that all receptor types were present in the various regions, except Drd3 in Area X, but there were very few noticeable differences between male and female canaries regarding dopamine receptor expression, which did not account for the differences in song.
  • The majority of dopamine receptor-expressing cells in the HVC area were linked to excitatory markers, while the PAG had lower receptor density and fewer inhibitory cells, and activation of these cells during
View Article and Find Full Text PDF

Background: Glioblastoma (GBM), a primary malignant brain tumor, has a poor prognosis, even with standard treatments such as radiotherapy and chemotherapy. In this study, we explored the anticancer effects of the synergistic combination of perphenazine (PER), a dopamine receptor D2/3 (DRD2/3) antagonist, and temozolomide (TMZ), a standard treatment for GBM, in patient-derived human GBM tumorspheres (TSs).

Methods: The biological effects of the combination of PER and TMZ in GBM TSs were assessed by measuring cell viability, ATP, stemness, invasiveness, and apoptosis.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how brain mechanisms related to cocaine use disorder involve both cortical and subcortical systems, emphasizing the importance of large-scale functional brain networks and the dopamine system.
  • - Previous research predominantly focused on cortico-striatal circuits, but this study shifts attention to how functional connectivity patterns are associated with neurotransmitter receptor densities in cocaine users.
  • - Findings reveal that specific patterns of connectivity in the brains of individuals with cocaine use disorder correspond with the spatial densities of dopamine D receptors, suggesting that these receptor distributions may influence brain connectivity associated with substance use.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!